EDG-2 Antibodies

Santa Cruz Biotechnology features a diverse variety of EDG-2 monoclonal antibodies for research focused on understanding EDG-2 protein functions. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EDG-2, also known as S1P receptor 2, is a member of the endothelial differentiation gene family and plays a crucial role in mediating the effects of sphingosine-1-phosphate (S1P) in cellular signaling pathways. EDG-2 is involved in various physiological processes, including immune response, vascular development, and cell migration. Research has shown that EDG-2 has significant implications in various diseases, including cancer and cardiovascular disorders. Understanding EDG-2 function continues to be a key focus in multiple research areas. Investigating EDG-2 expression and activity patterns provides valuable insights into disease mechanisms and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EDG-2 and its role in human health and disease.